These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37548011)

  • 1. Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.
    De Marchis GM; Krisai P; Werlen L; Sinnecker T; Aeschbacher S; Dittrich TD; Polymeris AA; Coslovksy M; Blum MR; Rodondi N; Reichlin T; Moschovitis G; Wuerfel J; Lyrer PA; Fischer U; Conen D; Kastner P; Ziegler A; Osswald S; Kühne M; Bonati LH;
    Stroke; 2023 Oct; 54(10):2542-2551. PubMed ID: 37548011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
    Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent cerebral infarcts in patients with atrial fibrillation: Clinical implications of an imaging-adjusted CHA2DS2-VASc score.
    Bretzman JP; Tseng AS; Graff-Radford J; Lee HC; Asirvatham SJ; Mielke MM; Knopman DS; Petersen RC; Jack CR; Vemuri P; Rabinstein AA; DeSimone CV
    Cardiol J; 2022; 29(5):766-772. PubMed ID: 35703042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA
    Jung M; Byeon K; Kang KW; Park YM; Hwang YM; Lee SH; Jin ES; Roh SY; Kim JS; Ahn J; Lee SR; Choi EK; Ahn MS; Lee EM; Park HC; Lee KH; Kim M; Choi JH; Ko JS; Kim JB; Kim C; Lip GYH; Shin SY;
    Yonsei Med J; 2022 Oct; 63(10):892-901. PubMed ID: 36168241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of CAS risk model and CHA
    Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
    J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
    Rivera-Caravaca JM; Marín F; Vilchez JA; Gálvez J; Esteve-Pastor MA; Vicente V; Lip GYH; Roldán V
    Stroke; 2019 Jun; 50(6):1372-1379. PubMed ID: 31084333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA
    Mu X; Qiu M; Li Y; Li Z; Qi B; Jing Z; Jing Q
    Clin Cardiol; 2023 Jul; 46(7):810-817. PubMed ID: 37218400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study.
    Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ
    Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
    Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Combining Left Atrial Diameter and Amino-terminal Pro-brain Natriuretic Peptide to the CHA2DS2-VASc Score for Predicting Stroke and Death in Patients with Sick Sinus Syndrome after Pacemaker Implantation.
    Mo BF; Lu QF; Lu SB; Xie YQ; Feng XF; Li YG
    Chin Med J (Engl); 2017 Aug; 130(16):1902-1908. PubMed ID: 28776540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
    Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.